Thanks to my tech-outfitted SUV, I have a life and career untethered from a single employer, a static workspace, and a ...

Qualcomm announced its entry into the AI data center market with the launch of its Dragonfly hardware portfolio and a $15 billion sector revenue goal by fiscal 2029. Designed to address the intense ...

The article " Qualcomm’s $4B AI Deal Takes Aim at NVIDIA’s Software Moat " first appeared on MarketBeat.

Qualcomm's data center entry analyzed: how the Modular acquisition, HBC memory architecture, and Arm-based C1000 CPU challenge NVIDIA in AI inference.

June 3 (Reuters) - Wildlife experts found eight new species of dragonfly, three unknown grasshoppers and some 60 new butterflies and moths in vivid hues during a trip to Angola's ‌Lisima plateau in ...

During his COMPUTEX 2026 keynote in Taipei, Qualcomm CEO Cristiano Amon introduced Dragonfly, a new brand that will cover the company’s future data center products. That includes server CPUs, AI ...

In 2034 NASA scientists will be flying around Titan. Remotely, of course—Titan, Saturn’s largest moon, is more than a billion kilometers away from Earth, a journey no human can yet make. It’s also ...

Dragonfly integration and testing—the activities involved in assembling the mission's rotorcraft lander and testing it for the rigors of launch and extreme conditions of space—is officially underway ...

The Cloud Native Computing Foundation (CNCF) announced recently that Dragonfly, its open source image and file distribution system, has reached graduated status, the highest maturity level within the ...

Dragonfly Capital has closed a $650 million fourth fund, one of the largest recent crypto venture capital raises despite a prolonged industry downturn. Managing partner Haseeb Qureshi said the firm is ...

RENO, Nev., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an industry leader in energy storage and maker of Battle Born ...

AbbVie has scrapped an asset from its ongoing collaboration with Dragonfly Therapeutics, a spokesperson for the Chicago pharma confirmed to Fierce Biotech. “We have terminated clinical activity around ...